Currently, no formalized international or UK-specific guidance exists to address these GLP-1 agonist-induced PET-CT interpretation challenges
We believe these data provide further validation of the RaniPill oral delivery platform across a wide variety of injectable obesity treatments
We identify melatonin as a previously unrecognized regulator of ILC2 metabolism and function
Losing and maintaining more than 10% of body weight is associated with significant reductions in obesity-related complications, including hypertension, type 2 diabetes, and heart disease
10 databases and registers Web of Science, Scopus, PubMed, APA PsycInfo, Embase, Ovid, Cochrane Library, CINAHL, Clinicaltrials.gov, and International Clinical Trials Registry Platform (ICTRP) were retrieved from the establishment to July 14, 2024 for related randomized controlled trials (RCT) and non-RCTs